Extracellular
deposition of β-amyloid (Aβ) peptide
aggregates is a major characteristic of Alzheimer’s disease
(AD) brain. Because Aβ peptide aggregates aggravate neuropathy
and cognitive impairment for AD patients, numerous efforts have been
devoted to suppressing Aβ self-assembly as a prospective AD
treatment option. Here, we report Aβ-targeting, red-light-responsive
carbon dots (CDs), and their therapeutic functions as a light-powered
nanomodulator to spatiotemporally suppress toxic Aβ aggregation
both in vitro and in vivo. Our aptamer-functionalized
carbon dots (Apta@CDs) showed strong targeting ability toward Aβ42 species. Moreover, red LED irradiation induced Apta@CDs
to irreversibly denature Aβ peptides, impeding the formation
of β-sheet-rich Aβ aggregates and attenuating Aβ-associated
cytotoxicity. Consequently, Apta@CDs-mediated photomodualtion modality
achieved effective suppression of Aβ aggregation in
vivo, which significantly reduced the Aβ burden at
the targeted sites in the brain of 5xFAD mice by ∼40% and ∼25%
according to imaging and ELISA analyses, respectively. Our work demonstrates
the therapeutic potential of photomodulating CDs for light-driven
suppression against Aβ self-assembly and related neurotoxicity.